OncoSil Medical Limited (OSL.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.71 Million AUD | -41.45% |
| 2023 | 11.47 Million AUD | -12.21% |
| 2022 | 13.06 Million AUD | -7.64% |
| 2021 | 14.15 Million AUD | -41.19% |
| 2020 | 24.05 Million AUD | 106.2% |
| 2019 | 11.66 Million AUD | -41.31% |
| 2018 | 19.88 Million AUD | 68.42% |
| 2017 | 11.8 Million AUD | -25.74% |
| 2016 | 15.89 Million AUD | 114.62% |
| 2015 | 7.4 Million AUD | -23.13% |
| 2014 | 9.63 Million AUD | 54.34% |
| 2013 | 6.24 Million AUD | 147.41% |
| 2012 | 2.52 Million AUD | -16.71% |
| 2011 | 3.03 Million AUD | 2.41% |
| 2010 | 2.95 Million AUD | -43.41% |
| 2009 | 5.22 Million AUD | -15.23% |
| 2008 | 6.16 Million AUD | -11.92% |
| 2007 | 7 Million AUD | -14.45% |
| 2006 | 8.18 Million AUD | 764.63% |
| 2005 | 946.59 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.43 Million AUD | 0.0% |
| 2024 Q4 | 6.71 Million AUD | 0.0% |
| 2024 FY | 6.35 Million AUD | -44.58% |
| 2023 FY | 11.47 Million AUD | -12.21% |
| 2023 Q4 | 11.47 Million AUD | 0.0% |
| 2023 Q2 | 7.62 Million AUD | 0.0% |
| 2022 FY | 13.06 Million AUD | -7.64% |
| 2022 Q2 | 7.96 Million AUD | 0.0% |
| 2022 Q4 | 13.06 Million AUD | 0.0% |
| 2021 Q2 | 19.03 Million AUD | 0.0% |
| 2021 Q4 | 14.15 Million AUD | 0.0% |
| 2021 FY | 14.15 Million AUD | -41.19% |
| 2020 FY | 24.05 Million AUD | 106.2% |
| 2020 Q4 | 24.05 Million AUD | 0.0% |
| 2020 Q2 | 8.43 Million AUD | 0.0% |
| 2019 Q4 | 11.66 Million AUD | 0.0% |
| 2019 FY | 11.66 Million AUD | -41.31% |
| 2019 Q2 | 15.29 Million AUD | 0.0% |
| 2018 Q4 | 19.88 Million AUD | 0.0% |
| 2018 Q2 | 7.82 Million AUD | 0.0% |
| 2018 FY | 19.88 Million AUD | 68.42% |
| 2017 Q4 | 11.8 Million AUD | 0.0% |
| 2017 FY | 11.8 Million AUD | -25.74% |
| 2017 Q2 | 12.67 Million AUD | 0.0% |
| 2016 Q4 | 15.89 Million AUD | 0.0% |
| 2016 FY | 15.89 Million AUD | 114.62% |
| 2016 Q2 | 7.46 Million AUD | 0.0% |
| 2015 Q2 | 10.45 Million AUD | 0.0% |
| 2015 FY | 7.4 Million AUD | -23.13% |
| 2015 Q4 | 7.4 Million AUD | 0.0% |
| 2014 Q2 | 14.28 Million AUD | 0.0% |
| 2014 FY | 9.63 Million AUD | 54.34% |
| 2014 Q4 | 9.63 Million AUD | 0.0% |
| 2013 Q2 | 2.37 Million AUD | 0.0% |
| 2013 FY | 6.24 Million AUD | 147.41% |
| 2013 Q3 | 6.24 Million AUD | 162.73% |
| 2013 Q4 | 6.24 Million AUD | 0.0% |
| 2013 Q1 | 2.37 Million AUD | -5.83% |
| 2012 FY | 2.52 Million AUD | -16.71% |
| 2012 Q4 | 2.52 Million AUD | 0.0% |
| 2011 FY | 3.03 Million AUD | 2.41% |
| 2011 Q4 | 3.03 Million AUD | 0.0% |
| 2010 FY | 2.95 Million AUD | -43.41% |
| 2010 Q4 | 2.95 Million AUD | 0.0% |
| 2009 Q4 | 5.22 Million AUD | 0.0% |
| 2009 FY | 5.22 Million AUD | -15.23% |
| 2008 FY | 6.16 Million AUD | -11.92% |
| 2008 Q4 | 6.16 Million AUD | 0.0% |
| 2007 Q4 | 7 Million AUD | 0.0% |
| 2007 FY | 7 Million AUD | -14.45% |
| 2006 FY | 8.18 Million AUD | 764.63% |
| 2006 Q4 | 8.18 Million AUD | 0.0% |
| 2005 FY | 946.59 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 94.402% |
| Adherium Limited | 9.88 Million AUD | 32.049% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 93.402% |
| Atomo Diagnostics Limited | 11.37 Million AUD | 40.958% |
| Anteris Technologies Ltd | 45.7 Million AUD | 85.299% |
| Control Bionics Limited | 9.02 Million AUD | 25.577% |
| CardieX Limited | 12.64 Million AUD | 46.889% |
| Compumedics Limited | 40.35 Million AUD | 83.353% |
| Cochlear Limited | 2.74 Billion AUD | 99.755% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 74.211% |
| Cyclopharm Limited | 45.91 Million AUD | 85.367% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 71.973% |
| Nova Eye Medical Limited | 29.88 Million AUD | 77.517% |
| HeraMED Limited | 2.95 Million AUD | -127.581% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | 44.823% |
| ImpediMed Limited | 46.98 Million AUD | 85.701% |
| InhaleRx Limited | 1.57 Million AUD | -326.056% |
| LBT Innovations Limited | 7.93 Million AUD | 15.289% |
| Micro-X Limited | 26.89 Million AUD | 75.02% |
| Neurotech International Limited | 12.21 Million AUD | 44.991% |
| PolyNovo Limited | 109.16 Million AUD | 93.846% |
| Respiri Limited | 6.19 Million AUD | -8.52% |
| SomnoMed Limited | 69.8 Million AUD | 90.375% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 77.695% |
| Uscom Limited | 5.13 Million AUD | -30.845% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | 40.043% |